幽门螺杆菌时代未做检查的消化不良管理的循证方法。加拿大消化不良工作组。

An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

作者信息

Veldhuyzen van Zanten S J, Flook N, Chiba N, Armstrong D, Barkun A, Bradette M, Thomson A, Bursey F, Blackshaw P, Frail D, Sinclair P

机构信息

Department of Medicine, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS.

出版信息

CMAJ. 2000 Jun 13;162(12 Suppl):S3-23.

DOI:
Abstract

OBJECTIVES

To provide Canadian primary care physicians with an evidence-based clinical management tool, including diagnostic and treatment recommendations, for patients who present with uninvestigated dyspepsia.

RECOMMENDATIONS

The management tool has 5 key decision steps addressing the following: (1) evidence that symptoms originate in the upper gastrointestinal tract, (2) presence of alarm features, (3) use of nonsteroidal anti-inflammatory drugs (NSAIDs), (4) dominant reflux symptoms and (5) evidence of Helicobacter pylori infection. All patients over 50 years of age who present with new-onset dyspepsia and patients who present with alarm features should receive prompt investigation, preferably by endoscopy. The management options for patients with uninvestigated dyspepsia who use NSAIDs regularly are: (1) to stop NSAID therapy and assess symptomatic response, (2) to treat with NSAID prophylaxis if NSAID therapy cannot be stopped or (3) to refer for investigation. Gastroesophageal reflux disease can be diagnosed clinically if the patient's dominant symptoms are heartburn or acid regurgitation, or both; these patients should be treated with acid suppressive therapy. The remaining patients should be tested for H. pylori infection, and those with a positive result should be treated with H. pylori-eradication therapy. Those with a negative result should have their symptoms treated with optimal antisecretory therapy or a prokinetic agent. VALIDATION AND EVIDENCE: Evidence for resolution of the dyspepsia symptoms was the main outcome measure. Supporting evidence for the 5 steps in the management tool and the recommendations for treatment were graded according to the strength of the evidence and were endorsed by consensus of committee members. If no randomized controlled clinical trials were available, the recommendations were based on the best available evidence.

LITERATURE REVIEW

Evidence was obtained from MEDLINE searches for pertinent articles published from 1966 to October 1999. The searches focused on dyspepsia, diagnosis and treatment. Additional articles were retrieved through a manual search of bibliographies and abstracts from international gastroenterology conferences.

摘要

目的

为加拿大基层医疗医生提供一种基于证据的临床管理工具,包括针对未作检查的消化不良患者的诊断和治疗建议。

建议

该管理工具包含5个关键决策步骤,涉及以下方面:(1)症状源自上消化道的证据;(2)警示特征的存在;(3)非甾体抗炎药(NSAIDs)的使用;(4)主要反流症状;(5)幽门螺杆菌感染的证据。所有50岁以上新发消化不良的患者以及有警示特征的患者都应接受及时检查,最好通过内镜检查。经常使用NSAIDs且未作检查的消化不良患者的管理选项为:(1)停止NSAID治疗并评估症状反应;(2)若无法停止NSAID治疗,则进行NSAID预防治疗;(3)转诊进行检查。如果患者的主要症状是烧心或反酸,或两者皆有,则可临床诊断为胃食管反流病;这些患者应接受抑酸治疗。其余患者应进行幽门螺杆菌感染检测,检测结果呈阳性的患者应接受根除幽门螺杆菌治疗。检测结果呈阴性的患者,其症状应采用最佳抑酸治疗或促动力药物进行治疗。

验证与证据

消化不良症状缓解的证据是主要结局指标。管理工具中5个步骤及治疗建议的支持证据根据证据强度进行分级,并经委员会成员一致认可。若没有随机对照临床试验,则建议基于现有最佳证据。

文献综述

证据来自对MEDLINE数据库中1966年至1999年10月发表的相关文章的检索。检索重点为消化不良、诊断和治疗。通过手动检索国际胃肠病学会议的参考文献和摘要获取了其他文章。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索